Company news
Oxford BioDynamics PLC news in 2017
Oxford BioDynamics PLC's news releases, calls and decks from 2017, newest first.
Exercise period extension existing Share Options
December 13, 2017
Exercise of warrants and director dealing
December 5, 2017
Data at FNIH Biomarker Consortium Cancer Meeting
November 15, 2017
Agreement with a major US biopharma company
November 7, 2017
Notification of major holdings
November 6, 2017
Presents at the Diabetes Asia 2017 Conference
October 13, 2017
Presents ALS signatures at NEALS
October 11, 2017
Announces grant of US patent for EpiSwitchT
October 3, 2017
Successful in diagnosing and staging breast cancer
September 28, 2017
Directorate Update
September 15, 2017
Appointment of Paul Stockdale as CFO
June 30, 2017
Targets Amyotrophic Lateral Sclerosis in Asia
June 13, 2017
Publication highlights advantages of EpiSwitchT
May 31, 2017
Development Agreements with Top Pharma Companies
May 23, 2017
Appointment of Shore Capital as Joint Broker
May 19, 2017
Subsidiary signs exclusive Asia licence
May 18, 2017
Representation on NIH steering committees
April 20, 2017
BIO-FLARE Collaboration
March 17, 2017
AGM Results and Related Party Transaction
March 15, 2017
Appointment of Martin Reeves as SVP
March 9, 2017
Appointment of Dr Claudio Carini
February 13, 2017
Pilot project with EpiFit
January 23, 2017